Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
about
Comparison of acute toxicities in two primary chemoradiation regimens in the treatment of advanced head and neck squamous cell carcinoma.Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservationRisk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancerCarotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinomaConcurrent radiochemotherapy in advanced hypopharyngeal cancerIntensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancerNon-invasive imaging of angiogenesis in head and neck squamous cell carcinomaAngiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma.Treatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancersA unique complication associated with concurrent chemoradiation for the treatment of locally advanced head and neck cancerDynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesTechnical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.A Retrospective Study of G-Tube Use in Japanese Patients Treated with Concurrent Chemoradiotherapy for Hypopharyngeal Cancer.Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experienceClinical evaluation of intensity-modulated radiotherapy for head and neck cancers.New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experienceAdvances in radiation therapy of head and neck cancer.Clinical application of intensity-modulated radiotherapy for head and neck cancer.The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.Conservative management of iatrogenic esophageal perforation in head and neck cancer patients with esophageal stricture.Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments.Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.A contemporary review of indications for primary surgical care of patients with squamous cell carcinoma of the head and neck.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?Reconstruction of pharyngeal defects with a submental island flap after hypopharyngeal carcinoma ablation.Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Intensity-modulated radiotherapy in definitive oncological treatment of hypopharyngeal squamous cell carcinoma.Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.Successful closure of pharyngo-cutaneous and phayryngo-tracheal fistulas using removable hypopharyngeal stent after laryngectomy for laryngeal carcinoma.IMRT: preliminary results in a series of advanced head-and-neck cancer patients.Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
P2860
Q33399402-B568E014-7829-48E2-BE62-A1946E3D2366Q33542810-321B68C4-EE57-43E0-AE95-B03E13562A64Q33891615-3F570D69-EBDA-49C2-B0CD-6775E56382F0Q33900752-640153D6-CAA1-4F83-A39C-BE685904B129Q33931220-100F4A2C-D1A5-48F3-9A0B-93A46C7B74C9Q33933913-D175EC26-B7FA-4449-B5B4-48C1FC1B0A9CQ34029591-804E6F21-DF8F-4BB0-81F3-8DC1DF7E82E4Q34101582-59198F48-B16B-4133-BF3A-D2811A886B8FQ34221226-BAF8A3DA-0C32-4A3C-B36C-AE7EC3DD6158Q34390975-66705622-87BA-4309-A34B-15DEA7BD7DF1Q34527573-540779C5-FDEF-4071-9213-A82EBDEAEAE3Q35019239-549FD65A-CE1E-4C85-99CE-387D9FE4BAC6Q35142863-58DEC7C9-660D-4AE3-A443-5DA4A80296F6Q35180964-08EAFCF4-2690-4992-BB2E-38CFE6408F17Q35223964-623214A4-7FCA-4679-A9EA-7379DDC817DBQ35534813-F3819440-0D8E-4D87-BDBA-6C1D181B70DFQ36111256-83091F7C-F941-4B53-B1D8-F3A921DD40C2Q36259231-2346A285-0A30-49FE-818F-9C9C6FE8D7FEQ36323993-945218A8-D341-41EB-B899-6A34711BEFC0Q36343896-46C71BB8-61D0-422D-84D0-E0A0B76319FCQ36807138-9A72F6B8-58AF-46B0-9CA3-7A6C6DFF7106Q37083138-4FB804BD-1EF3-46B6-93BE-78078ED78064Q37134458-DDBB0C0B-4DD0-48D4-8189-320C21CB4734Q37217016-4A548113-3112-4118-AFDE-CEF4542CB723Q37283393-4B55DD2E-E961-4209-9075-55AFD4FBF2B4Q37408337-F5EB817D-F5D9-442E-825B-BD29CE94A744Q37425697-F1CA9044-6CAA-4B9B-8039-705BE442B1CFQ37437083-DF743708-2665-45C6-8CCD-E3EFCB94B2F2Q37448728-396541DD-FEEF-4CA3-9BD8-3F10EEE3EE28Q37589552-51735973-69F8-413D-A065-9BF9238AC085Q37711059-C65E4633-7376-4649-8E8B-14D23C64521DQ37718044-4E730AA8-1501-4028-9C5B-4C27A82A136BQ38038841-2CC9D335-0A68-4EAD-8FD4-6578A9DDEF1DQ38069080-78DCF80B-903F-49F0-9AA4-CBE8C7457334Q38119441-E73C28D2-14AD-4D2A-84FD-25A452E7E697Q38237978-E8549D8A-3A29-48AC-9476-625E7A41750EQ39738530-FD43CD47-5EB8-4C4F-93C9-C865D4E7699AQ40831702-7ED32C6A-60FA-49C5-A7C2-7256F5D166F4Q42510603-577B8A07-8E63-4929-B03E-A83D7381ED8DQ43665506-154FF588-CC46-497D-8084-F9756F72E757
P2860
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@ast
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@en
type
label
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@ast
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@en
prefLabel
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@ast
Concurrent chemotherapy and in ...... al and hypopharyngeal cancers.
@en
P2093
P921
P1476
Concurrent chemotherapy and in ...... eal and hypopharyngeal cancers
@en
P2093
Ashwatha Narayana
Cesar Della-Bianca
David G Pfister
Dennis Kraus
Joanne Zhung
Kelvin Chan
Nancy Y Lee
Suzanne L Wolden
William O'Meara
P304
P356
10.1016/J.IJROBP.2007.03.013
P407
P577
2007-05-09T00:00:00Z